Literature DB >> 8803534

Frequencies of HLA-A24 and HLA-DR4-DQ8 are increased and that of HLA-B blank is decreased in chronic toxic oil syndrome.

A Arnaiz-Villena1, J Martinez-Laso, A Corell, L Allende, M Rosal, J J Gomez-Reino, J L Vicario.   

Abstract

The cause of toxic oil syndrome (TOS) has not yet been definitively determined, but some genetic susceptibility factors (certain HLA antigens and female sex) have been identified in 236 patients. Similarities with genetic factors for scleroderma and hydralazine-induced lupus (i.e. in TOS female sex and HLA-A24, Pcorrected = 0.00001 and DR4, Pcorrected = 0.04, respectively) may provide a clue to the responsible xenobiotic and its pathogenesis, and may also help in understanding the basis of the related eosinophilia-myalgia syndrome associated with tryptophan ingestion. In this paper it is also established that a human class I antigen (HLA-A24) and, independently, an HLA class II haplotype (DR4-DQ8, Pcorrected = 0.04) and arginine 52 in the alpha-DQ chains (Pcorrected = 0.03) are associated with TOS susceptibility, similarly to insulin-dependent diabetes. This further supports the classification of TOS as an autoimmune disease. Also, the increased frequency of a particular set of low-frequency HLA class I antigens in chronic TOS patients (i.e. B27, B37, B38 and B49) and the probable decrease in the frequency of HLA-B homozygotes in surviving patients (Pcorrected = 0.008) may provide an objective model to explain the maintenance of the HLA polymorphism: less frequent HLA alleles may be more advantageous in the event of unexpected human contact with unusual xenobiotics (not only microbes); however, other mechanisms working together to preserve and generate HLA polymorphism may coexist.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8803534     DOI: 10.1111/j.1744-313x.1996.tb00116.x

Source DB:  PubMed          Journal:  Eur J Immunogenet        ISSN: 0960-7420


  3 in total

1.  Drug-induced pulmonary arterial hypertension: a primer for clinicians and scientists.

Authors:  Mark E Orcholski; Ke Yuan; Charlotte Rajasingh; Halley Tsai; Elya A Shamskhou; Navneet K Dhillon; Norbert F Voelkel; Roham T Zamanian; Vinicio A de Jesus Perez
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-02-08       Impact factor: 5.464

2.  Immunogenetic risk and protective factors for the development of L-tryptophan-associated eosinophilia-myalgia syndrome and associated symptoms.

Authors:  Satoshi Okada; Mary L Kamb; Janardan P Pandey; Rossanne M Philen; Lori A Love; Frederick W Miller
Journal:  Arthritis Rheum       Date:  2009-10-15

Review 3.  The Spanish toxic oil syndrome 20 years after its onset: a multidisciplinary review of scientific knowledge.

Authors:  Emilio Gelpí; Manuel Posada de la Paz; Benedetto Terracini; Ignacio Abaitua; Agustín Gómez de la Cámara; Edwin M Kilbourne; Carlos Lahoz; Bénoit Nemery; Rossanne M Philen; Luis Soldevilla; Stanislaw Tarkowski
Journal:  Environ Health Perspect       Date:  2002-05       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.